These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

415 related items for PubMed ID: 31205266

  • 1. Differential Impact of Delayed Graft Function in Deceased Donor Renal Transplant Recipients With and Without Donor-specific HLA-antibodies.
    Haller J, Wehmeier C, Hönger G, Hirt-Minkowski P, Gürke L, Wolff T, Steiger J, Amico P, Dickenmann M, Schaub S.
    Transplantation; 2019 Sep; 103(9):e273-e280. PubMed ID: 31205266
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Graft immunologic events in deceased donor kidney transplant recipients with preformed HLA-donor specific antibodies.
    Ixtlapale-Carmona X, Arvizu A, De-Santiago A, González-Tableros N, López M, Castelán N, Marino LA, Uribe-Uribe NO, Contreras AG, Vilatobá M, Morales-Buenrostro LE, Alberú J.
    Transpl Immunol; 2018 Feb; 46():8-13. PubMed ID: 28974434
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Impact of Donor Specific HLA Antibody Monitoring After Kidney Transplantation.
    Rao S, Ghanta M, Lee IJ, Gillespie A, Parekh HK, Geier SS, Zeng X, Karachristos A, Lau KN, Karhadkar S, Di Carlo A, Sifontis NM, Constantinescu S.
    Clin Transpl; 2014 Feb; ():143-51. PubMed ID: 26281139
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Impact of HLA antibodies on graft survival in long-term renal recipients with functional grafts.
    Zeng Y, Liu Z, Liu Y, Fan Y, Guo Y, Qiu J.
    Urol Int; 2014 Feb; 92(3):328-33. PubMed ID: 24480999
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Clinical relevance of pretransplant anti-HLA donor-specific antibodies: does C1q-fixation matter?
    Crespo M, Torio A, Mas V, Redondo D, Pérez-Sáez MJ, Mir M, Faura A, Guerra R, Montes-Ares O, Checa MD, Pascual J.
    Transpl Immunol; 2013 Dec; 29(1-4):28-33. PubMed ID: 23907088
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Preformed donor-specific antibodies and risk of antibody-mediated rejection in repeat renal transplantation.
    Tsapepas DS, Vasilescu R, Tanriover B, Coppleson Y, Rekhtman Y, Hardy MA, Dube G, Crew RJ, Ratner LE, Cohen DJ, Mohan S.
    Transplantation; 2014 Mar 27; 97(6):642-7. PubMed ID: 24637863
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Donor-specific HLA-DQ antibodies may contribute to poor graft outcome after renal transplantation.
    DeVos JM, Gaber AO, Knight RJ, Land GA, Suki WN, Gaber LW, Patel SJ.
    Kidney Int; 2012 Sep 27; 82(5):598-604. PubMed ID: 22622504
    [Abstract] [Full Text] [Related]

  • 19. Prevalence and Clinical Impact of Donor-Specific Alloantibody Among Intestinal Transplant Recipients.
    Cheng EY, Everly MJ, Kaneku H, Banuelos N, Wozniak LJ, Venick RS, Marcus EA, McDiarmid SV, Busuttil RW, Terasaki PI, Farmer DG.
    Transplantation; 2017 Apr 27; 101(4):873-882. PubMed ID: 27490417
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.